KRT88P and liver disorder: The determination of the anti-HBc level (qAnti-HBc) was shown to provide further information on the status of immune activation in an infected individual and thus can help in the assessment of the phase of infection, stage of liver disease, and ability to reach therapy endpoints [8,9,10].